49 unknown. 49 Phase 3, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 49 | Unknown 49 |
| Phase 2 | 8 | Unknown 8 |
Follow Neoplasm Metastasis: new trials by email Literature Review of Neoplasm Metastasis trials Research Report on Neoplasm Metastasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia Liposomal cytarabine-daunorubicin for injection, 7+3 (cytarabine and daunorubicin) - High-risk (Secondary) Acute Myeloid Leukemia | Phase 3 | Unknown | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 120 | 2024-01-01 | 2023-12-28 |
| Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy SRT, Immunotherapy - Locally Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer | Phase 3 | Unknown | Institut Cancerologie de l'Ouest | 112 | 2022-01-12 | 2023-02-21 |
| CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients Chemotherapy - Colorectal Cancer, Circulating Tumor Cell | Phase 3 | Unknown | Fudan University | 100 | 2021-06-01 | 2021-06-08 |
| IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy Indocyanine Green - Gastric Cancer, Lymph Node Metastases | Phase 3 | Unknown | Fujian Medical University | 240 | 2020-11-16 | 2023-09-18 |
| TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study. Aflibercept-FOLFIRI, Aflibercept-mFOLFIRI3 - Cancer Colorectal, Metastasis | Phase 3 | Unknown | Hôpital Franco-Britannique-Fondation Cognacq-Jay | 202 | 2020-09-02 | 2023-10-23 |
| FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOX Gemcitabine, FOLFOX - Pancreatic Adenocarcinoma | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 400 | 2020-07-20 | 2020-08-18 |
| Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC) Sunitinib Malate, TAS 102 - Colorectal Cancer, Metastasis | Phase 2 / Phase 3 | Unknown | Amsterdam UMC, location VUmc | 60 | 2019-10-01 | 2020-11-13 |
| A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC HLX10, carboplatin and nab paclitaxel, Placebo - Squamous Non Small Cell Lung Cancer | Phase 3 | Unknown | Shanghai Henlius Biotech | 537 | 2019-08-14 | 2023-08-08 |
| Breast Cancer Active Surveillance, Alternative Option, Aspirin Included Aspirin Low Dose, Placebo Oral Tablet - Breast Cancer | Phase 2 / Phase 3 | Unknown | Centro Hospitalar Lisboa Ocidental | 60 | 2018-06-01 | 2018-04-09 |
| A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement) chemoradiation, Paclitaxel, Cisplatin - Cervical Cancer, Adjuvant Chemotherapy | Phase 3 | Unknown | Sun Yat-sen University | 432 | 2018-03-01 | 2018-03-26 |
| PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY Palbociclib, Placebo, Tamoxifen - Breast Neoplasms | Phase 3 | Unknown | National Cancer Center, Japan | 180 | 2018-02-09 | 2024-03-22 |
| A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers Beta-Glucan, Glutamine, Immunoglobuin - Metastatic Cancer, Chemotherapy | Phase 2 / Phase 3 | Unknown | E-DA Hospital | 90 | 2018-01-04 | 2021-01-25 |
| A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer Regorafenib, Placebo - Gastro-Oesophageal Cancer | Phase 3 | Unknown | Australasian Gastro-Intestinal Trials Group | 250 | 2016-11-01 | 2022-01-13 |
| M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma M-Vax- autologous, hapten-modified melanoma vaccine - Melanoma | Phase 3 | Unknown | AVAX Technologies | 387 | 2016-07-01 | 2015-12-03 |
| Huaier Granule As Adjuvant Therapy for Colorectal Cancer After Radical Surgery Huaier Granule - Colorectal Cancer | Phase 3 | Unknown | Sixth Affiliated Hospital, Sun Yat-sen University | 230 | 2016-06-01 | 2016-06-15 |
| Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer Huaier Granule, Oxaliplatin, Calcium folinate - Colorectal Cancer | Phase 3 | Unknown | Sixth Affiliated Hospital, Sun Yat-sen University | 230 | 2016-06-01 | 2016-06-08 |
| Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer Adjuvant chemotherapy (Paclitaxel and Cisplatin), Adjuvant radiotherapy, Control group (Surgery alone) - Esophageal Neoplasms | Phase 3 | Unknown | Shanghai Chest Hospital | 486 | 2016-01-01 | 2016-09-07 |
| Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer Everolimus, Exemestane, Fulvestrant - Metastatic Breast Cancer, Breast Cancer | Phase 3 | Unknown | Consorzio Oncotech | 745 | 2015-12-01 | 2016-06-15 |
| Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients Fulvestrant - Metastatic Breast Cancer | Phase 3 | Unknown | Consorzio Oncotech | 156 | 2015-11-01 | 2016-06-15 |
| Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized Trial Acetylsalicylic acid (ASA)/aspirin 200 mg daily, Acetylsalicylic acid (ASA)/aspirin 100 mg daily, Placebo - Colorectal Cancer | Phase 3 | Unknown | The Fourth Affiliated Hospital of Anhui Medical University | 3000 | 2015-10-01 | 2015-11-18 |
Showing 20 of 49. Sign in to see all of them.
Colorectal Neoplasms (16) · Breast Neoplasms (10) · Colonic Neoplasms (6) · Rectal Neoplasms (5) · Lymphatic Metastasis (4) · Brain Neoplasms (3) · Melanoma (3) · Carcinoma, Non-Small-Cell Lung (2) · Neoplasms (2) · Neoplasms, Unknown Primary (2) · Neoplastic Cells, Circulating (2) · Recurrence (2) · Uterine Cervical Neoplasms (2) · Adenocarcinoma (1)
Neoplastic Processes (49) · Pathologic Processes (49) · Pathological Conditions, Signs and Symptoms (49) · Neoplasms (47) · Neoplasms by Site (39) · Digestive System Diseases (21) · Digestive System Neoplasms (20) · Gastrointestinal Diseases (19) · Gastrointestinal Neoplasms (19) · Colonic Diseases (17) · Intestinal Diseases (17) · Intestinal Neoplasms (17) · Rectal Diseases (16) · Skin and Connective Tissue Diseases (13) · Skin Diseases (12)
Fluorouracil (10) · Leucovorin (9) · Capecitabine (4) · Chemotherapy, Adjuvant (4) · Neoadjuvant Therapy (3) · Oxaliplatin (3) · TP protocol (3) · Aspirin (2) · Bevacizumab (2) · Carboplatin (2) · Cetuximab (2) · Cisplatin (2) · Cytarabine (2) · Docetaxel (2) · Floxuridine (2)
Fudan University (3) · Sixth Affiliated Hospital, Sun Yat-sen University (3) · Consorzio Oncotech (2) · NeuroVita Clinic (2) · AVAX Technologies (1) · Academisch Ziekenhuis Maastricht (1) · Amsterdam UMC, location VUmc (1) · Assistance Publique - Hôpitaux de Paris (1) · Associació per a la Recerca Oncologica, Spain (1) · Australasian Gastro-Intestinal Trials Group (1) · Binghe Xu (1) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (1) · Centro Hospitalar Lisboa Ocidental (1) · Chang Gung Memorial Hospital (1) · Chinese Academy of Medical Sciences (1)
China (14) · United Kingdom (7) · France (6) · Germany (6) · Italy (5) · Netherlands (5) · United States (5) · Taiwan (4) · Canada (3) · Russia (3) · Australia (2) · Austria (2) · Belgium (2) · Japan (2) · New Zealand (2)
Andrey S. Bryukhovetskiy, MD (2) · John N. Primrose, MD (2) · Xiaojian Wu, Ph.D. (2) · Armando Santoro, MD (1) · Bernard Nordlinger, MD (1) · Binghe Xu, MD, Ph.D (1) · Binghe Xu, MD, PhD (1) · Chien-Sheng Tsai, M.D. (1) · Chyong-Huey Lai, M.D. (1) · David Cunningham, MD (1) · David J. Kerr, MD, FRCP, DSc (1) · Euan T. Walpole, MD (1) · Felix Bokstein, M.D. (1) · Francesco Cognetti (1)
PMID 20718753, PMID 22895629, PMID 23599758, PMID 25077927, PMID 25303679, PMID 25789053, PMID 11745440, PMID 12065558, PMID 12925241, PMID 14673047, PMID 15050330, PMID 18358928, PMID 19184641, PMID 19190462, PMID 19516944, PMID 19519435, PMID 19554377, PMID 19783374, PMID 20234364, PMID 20421764, PMID 20626450, PMID 21394500, PMID 21995387, PMID 22314329, PMID 24120480, PMID 24332514, PMID 25035292, PMID 25088940, PMID 25164541, PMID 26261259, PMID 26342674, PMID 26530541, PMID 27234640, PMID 27575024, PMID 27722750, PMID 27782851, PMID 28274254, PMID 28419193, PMID 29195117, PMID 30293873, PMID 30606259, PMID 31868905, PMID 32917529, PMID 33128132, PMID 33151266, PMID 33154570, PMID 33214446, PMID 35637412, PMID 36814222, PMID 37931185
2014 (2), 2019 (1)